Diagnostic and therapeutic criteria in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1

Journal of Internal Medicine

Volumn 243, Issue 6, 1998, Pages 489-494

  Mignon, M ^a   Cadiot, G ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

Digestive endocrine tumours; MEN 1; Primary hyperparathyroidism; Zollinger Ellison syndrome

Indexed keywords

PENTETREOTIDE;

ADULT; CANCER SCINTISCANNING; CARCINOID; CONFERENCE PAPER; ENDOSCOPIC ECHOGRAPHY; FEMALE; GASTRINOMA; HUMAN; HYPOPHYSIS ADENOMA; INSULINOMA; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE ENDOCRINE NEOPLASIA; PANCREATICODUODENECTOMY; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PROLACTINOMA; ZOLLINGER ELLISON SYNDROME;

EID: 0031809088     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1998.00287.x     Document Type: Conference Paper

References (42)

1. Norton JA, Doppman JL, Cornelius MJ et al. Effect of parathyroidectomy in patients with hyperparathyroidism and Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. Surgery 1987; 102: 958-66.
2. Chanson P, Cadiot G, Murat A, Genem 1. Management of patients and subjects at risk for multiple endocrine neoplasia type 1: MEN-1. Horm Res 1997; 47: 211-20.
3. Mignon M, Ruszniewski P, Podevin P, Sabbagh L, Cadiot G, Rigaud O, Bonfils S. Current approach to the management of gastrinoma and insulinoma in adults with multiple endocrine neoplasia type 1. World J Surg 1993; 17: 489-97.
4. Weber HC, Venzon DJ, Lin J-T, Fishbein VA, Orbuch M, Strader DB et al. Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology 1995; 108: 1637-49.
5. Kaplan EL, Horvath K, Udekwu A, Straus F, Schark C, Ferguson DJ, Skinner DB. Gastrinomas: a 42-year experience. World J Surg 1990; 14: 365-76.
6. Howard TJ, Sawicki MP, Stabile BE, Watt PC, Passaro E. Biologic behavior of sporadic gastrinoma located to the right and left of the superior mesenteric artery. Am J Surg 1993; 165: 101-6.
7. Ellison EC. Forty-year appraisal of gastrinoma. Back to the future. Ann Surg 1995; 222: 511-24.
8. Melvin WS, Johnson JA, Sparks J, Innes JT, Ellison EC. Long-term prognosis of Zollinger-Ellison syndrome in multiple endocrine neoplasia. Surgery 1993; 114: 1183-8.
9. Farley DR, van Heerden JA, Grant CS, Miller LJ, Ilstrup DM. The Zollinger-Ellison syndrome. A collective surgical experience. Ann Surg 1992; 215: 561-70.
10. Bardram L, Stage JG. Frequency of endocrine disorders in patients with the Zollinger-Ellison syndrome. Scand J Gastroenterol 1985; 20: 233-8.
11. Cadiot G, Houillier P, Allouch A, Paillard M, Mignon M, Gresze. Interest of the oral calcium tolerance test in the early diagnosis of primary hyperparathyroidism and multiple endocrine neoplasia type 1 in patients with the Zollinger-Ellison syndrome. Gut 1996; 39: 273-8.
12. Raue F, Zink A. Clinical features of multiple endocrine neoplasia type 1 and type 2. Horm Res 1992; 38: 31-5.
13. Benya RV, Metz DC, Venzon DJ, Fishbeyn VA, Strader DB, Orbuch M, Jensen RT. Zollinger-Ellison syndrome can be the initial endocrine manifestation in patients with multiple endocrine neoplasia-type 1. Am J Med 1994; 97: 436-44.
14. Skogseid B, Eriksson B, Lundqvist G, Lorelius L, Rastad J, Wide L et al. Multiple endocrine neoplasia type 1: a 10-year prospective screening study in four kindreds. J Clin Endocrinol Metab 1991; 73: 281-7.
15. Maton PN, Gardner JD, Jensen RT. Cushing's syndrome in patients with the Zollinger-Ellison syndrome. N Engl J Med 1986; 315: 1-5.
16. Ruszniewski P, Podevin P, Cadiot G, Marmuse JP, Mignon M, Vissuzaine Ch, et al. Clinical, anatomical, and evolutive features of patients with the Zollinger-Ellison syndrome combined with type 1 multiple endocrine neoplasia. Pancreas 1993; 8: 295-304.
17. Chiang H-CV, O'Dorisio TM, Huang SC, Maton PN, Gardner JD, Jensen RT, Multiple hormone elevations in Zollinger-Ellison syndrome. Prospective study of clinical significance and of the development of a second symptomatic pancreatic endocrine tumor syndrome. Gastroenterology 1990; 99: 1565-75.
18. Ross NS, Aron DC. Hormonal evaluation of the patient with an incidentally discovered adrenal mass. N Engl J Med 1990; 323: 1401-5.
19. Hall WA, Luciano MG, Doppman JL, Patronas NJ, Oldfield EH. Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med 1994; 120: 817-20.
20. Lehy T, Cadiot G, Mignon M, Ruszniewski P, Bonfils S. Influence of multiple endocrine neoplasia type 1 on gastric endocrine cells in patients with the Zollinger-Ellison syndrome. Gut 1992; 33: 1275-9.
21. Krishnamurthy S, Terminini B, Jensen RT, Dayal Y. Gastric endocrine cell status in familial and sporadic Zollinger-Ellison syndrome (abstract). Modern Pathol 1997; 9: 58A.
22. Cadiot G, Vissuzaine C, Potet F, Mignon M. Fundic argyrophil carcinoid tumor in a patient with sporadic-type Zollinger-Ellison syndrome. Dig Dis Sci 1995; 40: 1275-8.
23. Cadiot G, Laurent-Puig P, Thuille B, Lehy T, Mignon M, Olschwang S. Is the multiple endocrine neoplasia type I gene a suppressor for fundic argyrophil tumors in the Zollinger-Ellison syndrome? Gastroenterology 1993; 105: 579-82.
24. Padberg B, Schroder S, Capella C, Frilling A, Kloppel G, Heitz PU. Multiple endocrine neoplasia type 1 (MEN-1) revisited. Virchows Arch 1995; 426: 541-8.
25. Donow C, Pipeleers-Marichal M, Schroder S, Stamm B, Heitz PU, Kloppel G. Surgical pathology of gastrinoma. Site, size, multicentricity, association with multiple endocrine neoplasia type 1. Malignancy Cancer 1991; 68: 1329-34.
26. Mignon M, Cadiot G, Rigaud D, Ruszniewski PH, Jais P, Lehy T, Lewin MJM. Management of islet cell tumors in patients with multiple endocrine neoplasia type 1. In: Mignon M, Jensen RT, eds. Endocrine Tumors of the Pancreas. Recent Advances in Reserach and Management. (Frontiers in Gastrointestinal Research, Vol. 23.) Basel: Karger, 1995; 342-59.
27. Lamers CBHW. Gastrinoma in multiple endocrine neoplasia type 1. Acta Oncologica 1991; 30: 489-92.
28. Pipeleers-Marichal M, Somers G, Willems G, Foulis A, Imrie C, Bishop AE et al. Gastrinomas in the duodenum of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome. N Engl J Med 1990; 322: 723-7.
29. Macfarlane MP, Fraker DL, Alexander HR, Norton JA, Lubensky I, Jensen RT. Prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1. Surgery 1995; 118: 973-80.
30. Weber HC, Venzon DJ, Lin JT, Fishbein VA, Orbuch M, Strader DB et al. Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology 1995; 108: 1637-49.
31. Cadiot G, Doukhan I, Vuagnat A, Murat A, Bonnaud G, Ruszniewski P et al. GENEM 1 and GRESZE (abstract). Prognostic factors in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1: a French multicentric study in 71 patients. Gastroenterology 1997; 112: A431.
32. Gibril F, Reynolds JC, Doppman JL, Chen CC, Venzon DJ, Termanini B et al. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. Ann Intern Med 1996; 125: 26-34.
33. Zimmer T, Stölzel U, Bader M, Koppenhagen K, Hamm B, Buhr H et al. Endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localisation of insulinomas and gastrinomas. Gut 1996; 39: 562-8.
34. Ruszniewski PH, Amouyal P, Amouyal G, Grange JD, Mignon M, Bouche O, Bernades P. Localization of gastrinomas by endoscopic ultrasonography in patients with Zollinger-Ellison syndrome. Surgery 1995; 117: 629-35.
35. Cadiot G, Lebtahi R, Sarda L, Bonnaud G, Marmuse JP, Vissuzaine C et al. Preoperative detection of duodenal gastrinomas and peripancreatic lymph nodes by somatostatin receptor scintigraphy. Gastroenterology 1996; 111: 845-54.
36. Rösch T, Lightdale CJ, Botet JF, Boyce GA, Sivak Jr MV, Kenjiro Y et al. Localization of pancreatic endocrine tumors by endoscopic ultrasonography. N Engl J Med 1992; 326: 1721-6.
37. Palazzo L, Roseau G, Sameron M. Endoscopic ultrasonography in the preoperative localization of pancreatic endocrine tumors. Endoscopy 1992; 24 (Suppl. 1): 350-53.
38. Thompson NW, Czako PF, Fritts LL, Bude R, Bansal R, Nostrant TT, Scheiman JM. Role of endoscopic ultrasonography in the localization of insulinomas and gastrinomas. Surgery 1994; 116: 1131-8.
39. Cadiot G, Bonnaud G, Lebtahi R, Sarda L, Riszniewski P, Le Guludec G, Mignon M, Gresze. Usefulness of somatostatin receptor scintigraphy in the management of patients with Zollinger-Ellison syndrome. Gut 1997; 41: 107-14.
40. Termanini B, Gibril F, Reynolds JC, Doppman JL, Chen CC, Stewart CA et al. Value of somatostatin receptor scintigraphy: a prospective study in gastrinoma of its effect on clinical management. Gastroenterology 1997; 112: 335-47.
41. Fraker DL, Norton JA, Alexander R, Venzon DJ, Jensen RT, Surgery in Zollinger-Ellison syndrome alters the natural history of gastrinoma. Ann Surg 1994; 220: 320-30.
42. Thompson NW. The surgical management of hyperparathyroidism and endocrine disease of the pancreas in the multiple endocrine neoplasia type 1 patient. J Intern Med 1995; 238: 269-80.